AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

Similar documents
Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans

Award Number: W81XWH

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

Approved for public release; distribution unlimited

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

Approved for public release; distribution unlimited

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

Award Number: W81XWH

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Mission Connect Mild TBI Translational Research Consortium. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

Detection of Prostate Cancer Progression by Serum DNA Integrity

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

Promote Adjustment during Reintegration following Deployment

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029

TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls. Rachel Novotny, Ph.D. Honolulu, HI 96822

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Gulf War Illness Evaluation of an innovative detoxification program

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

TITLE: Exploring Early Detection Methods: Using the Intraductal Approach to Predict Breast Cancer

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

TITLE: Polychlorinated Biphenyls, Organochlorines & PD Risk: A Case Control Study in Alaska

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

TITLE: A Placebo-Controlled Augmentation Trial of Prazosin for Combat Trauma PTSD

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

Award Number: MIPR 3GD3DN3081. TITLE: Outcomes of Telehealth Group Psychosocial Interventions for Breast Cancer Patients and Their Partners

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

TITLE: Developing a Training Program in Breast Cancer Research to Decrease the Disparity of Morbidity and Mortality in Underserved/Minority Women

TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

TITLE: A Randomized Clinical Trial of the Collaborative Assessment and Management of Suicidality vs. Enhanced Care as Usual for Suicidal Soldiers

Decreasing Skin Graft Contraction through Topical Wound Bed Preparation with Anti-Inflammatory Agents. Tacoma, WA 98402

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

TITLE: Early Recognition of Chronic Traumatic Encephalopathy through FDDNP PET Imaging

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

TITLE: "Impact of Obesity on Tamoxifen Chemoprevention in a Model of Ductal Carcinoma in Situ"

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

CONTRACTING ORGANIZATION: University of Minnesota Minneapolis, MN

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

CONTRACTING ORGANIZATION: University of Texas M.D. Anderson Cancer Center Houston, TX 77030

Transcription:

1 AD (Leave blank) Award Number: W81XWH-09-1-0569 TITLE: Brief cognitive behavioral therapy for military populations PRINCIPAL INVESTIGATOR: M. David Rudd, PhD, ABPP CONTRACTING ORGANIZATION: University of Utah Salt Lake City, Utah 84122 REPORT DATE: October 2012 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: (Check one) X Approved for public release; distribution unlimited Distribution limited to U.S. Government agencies only; report contains proprietary information The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE (DD-MM-YYYY) 2. REPORT TYPE October 2012 Annual 4. TITLE AND SUBTITLE Brief cognitive behavioral therapy for military populations 2 3. DATES COVERED (From - To) 8September2011-7September2012 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-09-1-0569 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) M. David Rudd, PhD, ABPP 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER University of Utah Salt Lake City, Utah 84122 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, MD 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for public release; distribution unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT The purpose of this study is to compare a brief-cognitive behavioral therapy (B-CBT) to usual care in the treatment of active duty Service Members who report suicidal ideation with intent to die or those who make a suicide attempt. Enrollment, assessment, and treatment of study participants continues as planned without problems. To date, 161 subjects have consented to participate, of whom 140 have been randomized. 3-, 6-, 12-, and 18-month assessments have been initiated. Recruitment is occurring at a fast pace, with target enrollment (i.e., 150 participants total) projected to be achieved within the next month. 15. SUBJECT TERMS Suicide, military, cognitive-behavioral therapy, psychotherapy 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U c. THIS PAGE U UU 18. NUMBER OF PAGES 19a. NAME OF RESPONSIBLE PERSON USAMRMC 19b. TELEPHONE NUMBER (include area code)

3 Table of Contents Page Introduction..... 3 Body.. 3 Key Research Accomplishments... 5 Reportable Outcomes 5 Conclusion 6 References. 7 Appendices 7

4 INTRODUCTION The primary purpose of this study is to compare the effectiveness of brief cognitive-behavioral therapy (B-CBT) for the treatment of suicidality, including suicidal ideation and attempts (regardless of Axis I or II diagnosis) among active duty military personnel. The standard null hypothesis will involve tests conducted comparing improvement following B-CBT (treatment duration of 12 weeks) to treatment as usual (TAU). The primary outcome comparisons will include both direct markers of suicidality (i.e. suicide, suicide attempts) and indirect markers including associated symptomatology (i.e. suicidal ideation, intent, anxiety, depression, hopelessness, substance abuse, and sleep disturbance), along with remission of psychiatric diagnoses. Secondary purposes include the prospective investigation of suicide risk factors and warning signs to explore these variables ability to predict subsequent suicidal behavior following an index attempt. BODY All tasks outlined for the third year of the study have been accomplished. We hired two research therapists and have trained them to provide Brief Cognitive Behavioral Therapy (BCBT) for suicidal patients. We have continued to enroll participants, provided the experimental treatment, and conducted all follow-up assessments. Therapy sessions are reviewed by the Project Manager (Dr. Craig Bryan), with weekly supervision occurring between Dr. Bryan and each therapist. The independent evaluator also participates in supervision at least twice per month to ensure coding reliability and fidelity to inclusion/exclusion criteria. The database has been fully operational with no major problems in data storage or maintenance experienced. We have obtained annual renewal of IRB approvals from Madigan Army Medical Center (MAMC), the University of Utah, and the University of Texas Health Science Center at San Antonio (UTHSCSA). As of 1 September 2012, 164 have provided informed consent for study enrollment, of which 140 have met study criteria and been randomized to treatment. During the past year, we initiated the first 12- and 18-month follow-up assessments. Recruitment has accelerated over the past year, and we now anticipate closing enrollment within the next month. We submitted a request for a no-cost extension, which has been approved, to complete follow-up assessments for additional year, consistent with original study goals. All quarterly reports have been submitted. Several empirical manuscripts have been written and published, and several presentations at scientific conferences have been made based on the study findings, along with a host of additional manuscripts being planned. A treatment manual is being completed, will be published as a book, and will be widely distributed. We experienced minimal problems during the past year, and the study has been quite successful, despite the high-risk nature of the target population. As we approach the conclusion of this study, local mental health professionals at Fort Carson have expressed a strong desire for the study to continue as a designated treatment program (due to perceptions of significant benefit to the patient population). Specific tasks from the Statement of Work, along with current status are listed below. 24 to 36 months 1. Continue intake evaluations and follow-up assessments (1,3,6, 12,18 and 24 months) 2. Continue enrollment and administering study treatments 3. Continue entering research data into database useable tracking software program 4. Continue verification and cleaning of data set 5. Continue telephone conferences for coordinators, therapists, and research assistants 6. Continue monthly teleconference meetings with PIs, project coordinators and support staff 7. Continue data analyses, manuscript preparation and professional scientific presentations 8. Complete annual IRB progress reports at each site 9. Complete final IRB progress report at each site. 10. Complete quarterly technical progress reports

5 11. Complete final quarterly technical progress report 12. Complete final annual progress report to funding agency 13. Participate in final Principal Investigators Meeting in Fort Carson, Colorado Current status: 1. Intake evaluations and follow-up assessments have continued. As of 1 September 2012, we have evaluated 164 Soldiers for eligibility, of whom 140 have met inclusion criteria and have been randomized to one of the treatment conditions. 3-, 6-, 12-, and 18-month follow-up assessments have been continued with only five dropouts and four withdrawals thus far (i.e., a 94% retention rate thus far). 2. 140 participants have been enrolled and randomized two one of the two treatments. Treatments are being delivered as planned. 3. Self-report data continues to be entered directly by participants into our electronic database, and our evaluator continues to enter clinician interview data within 24 hours of assessment. 4. Data has been screened and reviewed periodically, and identified errors have been corrected within 72 hours of identification. 5. Telephone conferences continue weekly for the coordinator, therapists, and evaluator. 6. Telephone conferences continue monthly to twice per month for investigators and coordinators. 7. Two quantitative analysis papers have been published during the past year, and seven conference proposals have been presented or are scheduled to be presented in the coming months at scientific meetings. 8. The annual IRB progress reports have been on schedule. 9. N/A study is still ongoing. 10. Quarterly reports have been submitted on time. 11. N/A study is still ongoing. 12. N/A study is still ongoing. 13. N/A study is still ongoing, but a final investigators meeting is tentatively scheduled for this winter. KEY RESEARCH ACCOMPLISHMENTS Obtaining IRB annual approval/renewal Nearing completion of enrollment Continuation of study treatment and assessments Fidelity monitoring of therapists and evaluator Publication of first quantitative analyses Nearing publication of treatment manual and launching of related training effort REPORTABLE OUTCOMES In terms of scholarly activity resulting from this project in the past year, two quantitative analyses have been written up and subsequently published. A number of additional manuscripts are in process, with an emphasis on those targeting treatment outcome and effectiveness. Seven conference proposals have been accepted at the following scientific conferences: Association of Behavioral and Cognitive Therapies, November 2011 (2 presentations); American Association of Suicidology, April 2012 (2 presentations); Association of Behavioral and Cognitive Therapies, November 2012 (1 presentation scheduled); American Association of Suicidology, April 2013 (2 presentations scheduled). The PI (Dr. David Rudd) and Project Manager (Dr. Craig Bryan) are additionally nearing completion of the final version of the treatment manual and manuscript to be published in the form of a text book. Based on the initial success and outcomes of the current project, Dr. Rudd and Dr. Bryan have regularly been featured in the media to discuss military suicide. A full list of media appearances within the past year can be found at www.veterans.utah.edu/media.html. Dr. Bryan continues to conduct workshops

6 across the country for mental health professionals to teach BCBT for suicidal patients, and Dr. Rudd continues to work with Congressional leaders to improve treatment options and mental health care for suicidal service members. A follow-up treatment study focused on acute interventions for suicidal Soldiers was funded last year, and has just recently received IRB approval. It is expected that the new study will begin at Fort Carson within the next few months, following the close of the current study, using the same staff and personnel involved in the current study. The possibility of additional treatment studies is being explored. Research staff members and collaborators have benefited from this project via increased opportunities for advanced training and professional development. Study therapists Sharon Stone and Kim Arne received intensive training in military mental health and prolonged exposure therapy for PTSD at the Center for Deployment Psychology in Bethesda, MD. Kim Arne and Sean Williams have continued to receive formal supervision hours required for licensure from Dr. Evelyn Wertenberger, and both are scheduled to take their final examinations for independent licensure by the end of this year. CONCLUSION The third year of this study has resulted in the continuation of enrollment and study procedures, and has seen considerable success in recruitment that has brought the project to near completion. A no-cost extension was requested and approved, which will enable us to finish enrollment within the next month and continue follow-up assessments for another year. The project has benefited significantly from the close involvement and collaboration of Army clinicians and leadership, who have continued to support the study. Results of several initial empirical analyses have yielded important information about the primary motivations behind Soldiers suicide attempts and the most common stressors experienced by Soldiers on the day of their suicide attempts. Subsequent analysis will explore treatment outcomes across a broad range of markers, examining the utility and effectiveness of a brief intervention for suicidality. In addition to improvement in soldier overall mental health and related functioning, the fiscal implications and potential savings will be explored. These results have had a direct impact on Army leadership, and have provided scientific data to support Army initiatives related to supporting the mental health needs of Soldiers. Feedback from other medical providers involved in the treatment and care of our participants has continued to be extremely positive, and it is expected that a larger-scale roll-out of training in BCBT at Fort Carson and other sites would be welcomed.

7 REFERENCES Bryan, C.J., & Rudd, M.D. (2012). Life stressors, emotional distress, and trauma-related thoughts occurring within 24 hours of suicide attempts among active duty U.S. Soldiers. Journal of Psychiatric Research, 46, 843-848. Bryan, C.J., Rudd, M.D., & Wertenberger, E. (in press). Reasons for suicide attempts among active duty Soldiers: a functional approach. Journal of Affective Disorders APPENDICES Current financial report. SUPPORTING DATA None

8 ANNUAL REPORT 2 Report Date 9/5/12 Reporting period from 9/8/11 to 9/7/12 PI M. David Rudd Telephone No. 801-581-8620 InstitutionThe University of Utah Project Title: Brief Cognitive Behavioral Therapy for Military Populations Current staff, with percent effort of each on project. Rudd, M. David 17% Williams, Sean 50% Bryan, Craig 75% Arne, Kimberly 50% Stone, Sharon 50% Award expenditures to date (as applicable): This Qtr/Cumulative Personnel 44,761.15 / 446,927.26 Fringe Benefits _13,997.52 / 133,586.59 This Qtr/Cumulative Travel 2,850.07 / 41,988.70 Equipment/Facility Rental/User Fees 0_/ 4,101.40 non-capital Materials/Supplies 0 / 11,466.80 Participant/Trainee Support 0 / 0 Subject Costs 0 / 0 Sub-award costs 34,411.08 / 538,515.65 Consultant Services 0 / 1,500.00 Other Direct Costs 0 / 2,566.55 This Qtr/Cumulative Subtotal 96,021.82 / 1,180,652.95 Indirect Costs 30,496.36 / 333,343.83 Fee 0 / 0 Total 126,518.18 / 1,513,996.78 Comments on administrative and logistical matters. Award expenditures as of 8/31/12, based on University financial reporting systems. Use additional page(s), as necessary, to describe scientific progress for the quarter in terms of the tasks or objectives listed in the statement of work. Use additional page(s) to present a brief statement of plans or milestones for the next quarter.